
Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms?
Author(s) -
Cristina Tecchio,
Irina Magdalena Dumitru,
Luana Alexandrescu,
Lucian Cristian Petcu,
Eugen Dumitru
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000024059
Subject(s) - rifaximin , medicine , irritable bowel syndrome , bloating , gastroenterology , abdominal pain , calprotectin , inflammatory bowel disease , crohn's disease , small intestinal bacterial overgrowth , diarrhea , disease , antibiotics , microbiology and biotechnology , biology